FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088874 [Registered on: 16/06/2025] Trial Registered Prospectively
Last Modified On: 15/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A comparison of 2 medicine, for spinal anesthesia in lower limb surgeries in adult patients. 
Scientific Title of Study   A randomized comparative study between hyperbaric levobupivacaine and hyperbaric levobupivacaine with dexmedetomidine in lower limb surgeries in adult patients under subarachnoid block 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Biruj Mahalia 
Designation  Junior Resident 
Affiliation  Lala Lajpat Rai Memorial Medical College 
Address  Department of Anaesthesiology, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, 250004 India
Department of Anaesthesiology, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, 250004 India
Meerut
UTTAR PRADESH
250004
India 
Phone  9582338327  
Fax    
Email  birujmahalia7272@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sangeeta Varun 
Designation  Associate Professor 
Affiliation  Lala Lajpat Rai Memorial Medical College 
Address  Department of Anaesthesiology, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, 250004 India
Department of Anaesthesiology, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, 250004 India
Meerut
UTTAR PRADESH
250004
India 
Phone  9568766156  
Fax    
Email  nickysangeeta78@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Biruj Mahalia 
Designation  Junior Resident 
Affiliation  Lala Lajpat Rai Memorial Medical College 
Address  Department of Anaesthesiology, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, 250004 India
Department of Anaesthesiology, Lala Lajpat Rai Memorial Medical College, Meerut, Uttar Pradesh, 250004 India
Meerut
UTTAR PRADESH
250004
India 
Phone  9582338327  
Fax    
Email  birujmahalia7272@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology Lala Lajpat Rai Memorial Medical college Meerut Uttar Pradesh 250004 
 
Primary Sponsor  
Name  LLRM medical college 
Address  Department of Anaesthesiology Lala Lajpat Rai Memorial Medical college Meerut Uttar Pradesh 250004 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Biruj Mahalia  Lala Lajpat Rai Memorial Medical College Meerut  Department of Anaesthesiology, Lala Lajpat Rai Memorial Medical College, Meerut, 250004, Uttar Pradesh
Meerut
UTTAR PRADESH 
9582338327

birujmahalia7272@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Office of the principal, LLRM medical college, meerut,Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S82||Fracture of lower leg, including ankle, (2) ICD-10 Condition: S82||Fracture of lower leg, including ankle,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Inj. Levobupivacaine heavy 0.5%  Inj. Levobupivacaine heavy 0.5% 15mg injected in Lumber 3rd and lumber 4th intervertebral subarachnoid space of spine. 
Comparator Agent  Inj. Levobupivacaine heavy 0.5% 15mg plus 5mcg inj Dexmedetomidine.  Inj. Levobupivacaine heavy 0.5% 15mg plus 5mcg inj Dexmedetomidine injected in between lumber 3rd and Lumber 4th intervertebral subarachnoid space of spine. 
Intervention  Subarachnoid block  Drug is given in Lumber 3rd and lumber 4th intervertebral subarachnoid space in all participants of the study. Onset and duration of sensory and motor blockade evaluated. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  ASA grade 1 and 2, age 18-65 years of either sex, patient undergoing elective lower limb surgeries. 
 
ExclusionCriteria 
Details  Patient refusal, ASA grade 3 and 4, known allergy or hypersensitivity to local anaesthesic drugs, infection at the injection site, bleeding diathesis or coagulopathy, pre existing ischaemic heart disease, diabetes mellitus and hypertension, CNS disorder-epilepsy and raised intracranial tension, severe renal, hepatic, hematological, metabolic disorder, cardiac malformation, spinal deformity, pregnancy, COPD, Asthma, chronic bronchitis. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate and compare the efficacy of the drugs  Onset of sensory and motor blockade will be assessed at different time intervals till the complete effect or for 30 minutes after injection.
 
 
Secondary Outcome  
Outcome  TimePoints 
To compare and evaluate onset and duration of sensory block in both the groups, to compare and evaluate onset and duration of motor block in both groups.  Sensory and motor blockade will be evaluated every 1 minute for initial 5 min and every 2 min for next 10 min till the complete effect. 
Hemodynamic changes if any- heart rate, mean arterial pressure, systolic blood pressure , diastolic blood pressure, SpO2.  Heart rate, mean arterial pressure, systolic blood pressure , diastolic blood pressure, SpO2 will be recorded immediately after procedure and every 2 min for initial 10 min, every 5 min for next 30 min and at 15 min interval till completion of the surgery. 
To compare and evaluate time of first rescue analgesia in both groups.  Patient to be assessed for 12 hours for rescue analgesia 
Complications  Patient to be assessed for 24 hours post operatively. 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is prospective randomized comparative study between hyperbaric levobupivacaine and hyperbaric levobupivacaine with dexmedetomidine in lower limb surgeries in adult patients under subarachnoid block. Primary objective of this study is to compare the efficacy of the drugs and to compare and evaluate the onset and duration of sensory and motor blockade in both the study groups. Hemodynamic changes- heart rate, mean arterial pressure, systolic and diastolic blood pressure. Also to compare and evaluate time of first rescue analgesia and complications if any. 
Close